Castle Biosciences
CSTL
CSTL
170 hedge funds and large institutions have $604M invested in Castle Biosciences in 2025 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 61 increasing their positions, 53 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
11% more capital invested
Capital invested by funds: $542M → $604M (+$62M)
0.47% less ownership
Funds ownership: 91.91% → 91.44% (-0.47%)
Holders
170
Holding in Top 10
1
Calls
$984K
Puts
$216K
Top Buyers
| 1 | +$16.1M | |
| 2 | +$9.11M | |
| 3 | +$7.67M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$4.77M |
| 5 |
Millennium Management
New York
|
+$3.34M |
Top Sellers
| 1 | -$14.5M | |
| 2 | -$8.67M | |
| 3 | -$8.32M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$3.43M |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$3.18M |
